Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin versus hydroxyethyl starch for pump priming in adult heart valve surgery
IRCT20190512043568N1Phase 3Completed
- Sponsor
- Ragaei Heart Center
- Start
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Cardiac valve disease (VHD) comparing Albumin prime solution with Hydroxyethyl starch prime solution (2 arms). Primary endpoints: Coagulation parameters, Blood product use and 2 more. Started Jan 2019; status: completed.
02
Drugs
albumin (human)hetastarch
03
Conditions
Cardiac valve disease (VHD)
Beyond the preview
Go deeper on IRCT20190512043568N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190512043568N1.